Voyager Therapeutics (VYGR) Other Non-Current Assets (2014 - 2026)

Voyager Therapeutics (VYGR) has 13 years of Other Non-Current Assets data on file, last reported at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 4.8% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (down 4.8% YoY), and the FY2025 full-year result was $2.7 million, down 4.8% from the prior year.
• Other Non-Current Assets held at $2.7 million in Q1 2026, from $2.7 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $5.6 million in Q3 2025 to a low of $1.5 million in Q2 2022.
• A 5-year average of $2.4 million and a median of $2.7 million in 2025 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets tumbled 32.58% in 2022 and surged 95.34% in 2025, its largest moves.
• Tracing VYGR's Other Non-Current Assets over 5 years: stood at $1.5 million in 2022, then advanced by 5.15% to $1.6 million in 2023, then jumped by 80.41% to $2.9 million in 2024, then retreated by 4.8% to $2.7 million in 2025, then changed by 0.0% to $2.7 million in 2026.
• Business Quant data shows VYGR's Other Non-Current Assets at $2.7 million in Q1 2026, $2.7 million in Q4 2025, and $5.6 million in Q3 2025.